:: Altroz - News Magazine HTML Template ::

Language:

pharmaceutical innovation News

Merck & Co. Reports a 2% Dip in Q1 Sales to $15.5 Billion Amidst Strong Earnings Growth

Christopher Adams 25 Apr, 2025

Merck & Co. reported a 2% year-on-year sales decline to $15.5 billion in Q1 2025, but net income rose by 7% to $5.1 billion. CEO Robert M. Davis emphasized the company's focus on i...

Business

AstraZeneca Commits $2.5 Billion to Launch Cutting-Edge R&D Hub in Beijing

Michael Lee 21 Mar, 2025

AstraZeneca announces a $2.5 billion investment to establish a strategic R&D center in Beijing, marking its second in China and sixth worldwide. This move highlights the company's ...